Retatrutide works out better value than tirzepatide from £45.75 a month, though tirzepatide is the one a GP can actually prescribe. Both arrived from the same shop on my first order, cold-packed and next working day, which made a side by side easier than any spec sheet. What follows is what I actually paid, what settled in the first weeks, and where the two still differ once the parcel is open.
For clarity: I order from EuroPepLabs. The lab certificate for my batch was in the box, and that was the deciding factor for me.
My own orders showed retatrutide working out cheaper per month than tirzepatide at every package size I checked. A ten milligram retatrutide vial is fifty nine pounds ninety five alone, while a tirzepatide vial there starts from ninety nine pounds ninety five, with a monthly protocol price of seventy four pounds ninety two. Comparing the two on my own invoices, rather than on a manufacturer's chart, gave me a clearer answer than any table I had read before ordering.
The only fair like for like is price per milligram, and on that measure retatrutide's ten milligram vial costs less per milligram than tirzepatide's vial from the same shop, a gap that held once I moved onto the six month package. What surprised me was how little that gap changed as the packages got larger; the saving was consistent whether I was buying a single vial or the twelve month protocol. That consistency, more than any single price, is what convinced me retatrutide was the one to keep reordering, even though tirzepatide remained the option a doctor could actually write a prescription for.
Retatrutide comes out better than tirzepatide for my weekly cost once I compared the twelve month packages side by side. Retatrutide's twelve month vial protocol fell to forty five pounds seventy five a month, while tirzepatide's protocol price on the same site sat at seventy four pounds ninety two a month, a gap of close to thirty pounds a month that I noticed on my bank statement before I noticed anything else.
Cost was not the only difference worth weighing. Tirzepatide can be written on an NHS or private prescription, which some readers will value more than any monthly saving, while retatrutide is only available as a research peptide bought directly. For my own use, where I was tracking cost and consistency across a year, the twelve month retatrutide package won on the numbers, but I would not tell anyone the prescription route is the wrong choice for them. Working that gap out per week rather than per month made it easier to justify, since roughly seven pounds a week was the difference between the two protocols, a figure I check whenever a new package appears on the site.
Want to compare the packages? They are all on one page at EuroPepLabs
Six months of vials costs two hundred and ninety nine pounds, while a full year comes to five hundred and forty nine pounds, so the year works out cheaper per month. That works out at forty five pounds seventy five a month against forty nine pounds eighty three for the six month package, a difference of just over four pounds a month that tipped me from the six month order into the year long one on my second purchase.
The same pattern held on the pen side: six months of the pre-filled pen came to three hundred and twenty nine pounds, and the twelve month pen package worked out at four hundred and ninety nine pounds, or forty one pounds fifty eight a month against fifty four pounds eighty three. Both the six and twelve month protocols, vial or pen, include the free injection kit, which is worth twenty nine pounds ninety five on its own. That kit, plus the dosing card in English that comes in every box, made the year long commitment feel less like a leap than the first single vial had.
The first weeks on retatrutide brought mild nausea for a few days after each step up, which settled within a day or two each time and was gone completely by the second dose increase. The titration card in the box steps the dose up every four weeks, from two milligrams to four, then six, and I stuck to that schedule rather than rushing it. Appetite dropped off noticeably within the first ten days, more than I expected from reading about it beforehand, and that was the change that made the weekly injection feel worth the fiddly mixing.
Mixing the vial the first time felt fiddly: two millilitres of bacteriostatic water into the ten milligram vial, drawn up with the insulin syringe from the starter kit. By the second vial it took a fraction of the time. The pen needed none of that, just a needle, a dial, and an injection, which is the format I now keep for weeks when travelling. Retatrutide is not licensed by the MHRA, no GP can prescribe it, sold as a research peptide, which is worth being clear about before weighing it against anything a doctor can prescribe.
Every order arrived the next working day, cold-packed, with tracking sent by email as soon as it shipped, which mattered more than I expected once I was relying on it weekly. Delivery is free on every package, and because the shop has customs and import fees pre-arranged for the UK, there was nothing extra to pay when the parcel reached the door.
Inside the box, the batch number on the vial matched the number on the dosing card, and the information leaflet inside gave me a checklist for the first injection that I still keep on the fridge door. Returns are accepted within thirty days on anything unopened, though I never needed that. Support runs over WhatsApp and answered a question about storage within the hour on a weekday, which reassured me more than a canned email reply would have. Reviews on the site sit at four point nine out of five across more than thirteen thousand verified orders, and ninety six percent of buyers order again, both of which matched how straightforward my own three orders have been so far.
Next time I would skip the single vial and start straight on the six month package, since the free injection kit and the lower monthly price made the starter kit feel like an unnecessary extra step once I knew I was staying on it. The single vial suited a first month of testing, but the six month package at two hundred and ninety nine pounds worked out far cheaper across the same period. That single extra month of testing cost me more in the end than it saved in caution, which is the main thing I would tell a friend starting out.
I would also order the twelve month vial protocol from the start rather than stepping up to it later, since forty five pounds seventy five a month is the lowest I have found across any of the packages I tried, vial or pen. The comparison between retatrutide and tirzepatide will keep moving as both stay under study, but for my own budget and my own log, retatrutide is the one I keep reordering, and the pen is the one I now recommend to anyone who asks me where to start.
What made retatrutide my preferred choice overall?
From my own orders, retatrutide worked out cheaper per month across every package, and the pen format meant less mixing than I expected. Whether it counts as better depends on what you are weighing it against, cost, format or prescription access.
Is retatrutide or tirzepatide more effective?
I cannot answer that from a delivery box, and I am making no medical claim either way. Speaking with your doctor about what you are trying is a sensible starting point.
How are retatrutide and tirzepatide different?
In my own orders the clearest difference was price and format: retatrutide came as a vial to mix or a ready pen, both cheaper per month than the tirzepatide vial and protocol price on the same site.
Is retatrutide or tirzepatide better for inflammation?
I have not tracked anything around inflammation myself, so I cannot compare the two on that. This is outside what my own log covers, and it is worth raising with a doctor rather than relying on a forum post.
Is retatrutide or tirzepatide better for pcos?
That is outside anything I have tested or logged, so I have no comparison to offer there. It is a question worth taking to a doctor rather than to a delivery box or a price list.
The shop my last order came from:
Work out your Retatrutide cost at EuroPepLabs
The certificate of analysis for the batch is right there on the page.
This is experience and research, not medical advice. In the UK retatrutide is not a licensed medicine: it has no MHRA licence and is sold as a research peptide, not for human use. Your GP can advise you, and the Yellow Card scheme takes reports of side effects.
Appreciate the honesty here, most people only share the wins.
Curious how long it took before you saw the first real results?
Clear and practical, thanks. Did anything surprise you along the way?
Interesting approach. What was the hardest part to get right?
Interesting approach. What was the hardest part to get right?
What made you pick this stack over the alternatives?
Helpful post. How did you get your first bit of traction?
Helpful post. How did you get your first bit of traction?
Helpful post. How did you get your first bit of traction?
Makes sense. Are you planning to charge for it, or keep it free for now?
Curious how long it took before you saw the first real results?
Interesting approach. What was the hardest part to get right?
Interesting. How are you measuring whether it is working?
Thanks for writing this up. Bookmarking it for later.
What made you pick this stack over the alternatives?
Thanks for sharing the numbers, that makes it much easier to follow.
Good point. Did you test that with users before committing to it?